Multiple Endocrine Neoplasia Research 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Tumor-to-Tumor Metastasis of Medullary Thyroid Carcinoma to Paraganglioma in a Multiple Endocrine Neoplasia Type 2B Patient: A Case Report and Literature Review
Tohoku J Exp Med. 2023 Jul 20. doi: 10.1620/tjem.2023.J058. Online ahead of print.NO ABSTRACTPMID:37468258 | DOI:10.1620/tjem.2023.J058 (Source: The Tohoku Journal of Experimental Medicine)
Source: The Tohoku Journal of Experimental Medicine - July 19, 2023 Category: Research Authors: Naruhito Takido Ryusuke Saito Kaoru Okada Norifumi Kanai Yoshihiro Shono Hiroaki Mitsugashira Muneyuki Matsumura Kengo Sasaki Koji Miyazawa Atsushi Fujio Kazuaki Tokodai Keigo Murakami Hironobu Sasano Michiaki Unno Takanori Ishida Takashi Kamei Source Type: research
Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas
CONCLUSIONS: Of all the features evaluated, only the multifocal nature of pancreatic neuroendocrine tumour (PanNET) lesions and a positive family history differentiated between patients with sporadic and MEN-1-related insulinomas. An age of insulinoma diagnosis of less than 30 years may be a strong indicator of an increased risk of MEN-1 syndrome.PMID:37431872 | DOI:10.5603/EP.a2023.0049 (Source: Endokrynologia Polska)
Source: Endokrynologia Polska - July 11, 2023 Category: Endocrinology Authors: Marta Opali ńska Aleksandra Gilis-Januszewska Karolina Morawiec-S ławek Anna Kurzy ńska Anna Sowa-Staszczak Anna Bogus ławska Ewelina Rzepka Alicja Hubalewska-Dydejczyk Source Type: research
Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas
CONCLUSIONS: Of all the features evaluated, only the multifocal nature of pancreatic neuroendocrine tumour (PanNET) lesions and a positive family history differentiated between patients with sporadic and MEN-1-related insulinomas. An age of insulinoma diagnosis of less than 30 years may be a strong indicator of an increased risk of MEN-1 syndrome.PMID:37431872 | DOI:10.5603/EP.a2023.0049 (Source: Endokrynologia Polska)
Source: Endokrynologia Polska - July 11, 2023 Category: Endocrinology Authors: Marta Opali ńska Aleksandra Gilis-Januszewska Karolina Morawiec-S ławek Anna Kurzy ńska Anna Sowa-Staszczak Anna Bogus ławska Ewelina Rzepka Alicja Hubalewska-Dydejczyk Source Type: research
Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas
CONCLUSIONS: Of all the features evaluated, only the multifocal nature of pancreatic neuroendocrine tumour (PanNET) lesions and a positive family history differentiated between patients with sporadic and MEN-1-related insulinomas. An age of insulinoma diagnosis of less than 30 years may be a strong indicator of an increased risk of MEN-1 syndrome.PMID:37431872 | DOI:10.5603/EP.a2023.0049 (Source: Endokrynologia Polska)
Source: Endokrynologia Polska - July 11, 2023 Category: Endocrinology Authors: Marta Opali ńska Aleksandra Gilis-Januszewska Karolina Morawiec-S ławek Anna Kurzy ńska Anna Sowa-Staszczak Anna Bogus ławska Ewelina Rzepka Alicja Hubalewska-Dydejczyk Source Type: research
Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas
CONCLUSIONS: Of all the features evaluated, only the multifocal nature of pancreatic neuroendocrine tumour (PanNET) lesions and a positive family history differentiated between patients with sporadic and MEN-1-related insulinomas. An age of insulinoma diagnosis of less than 30 years may be a strong indicator of an increased risk of MEN-1 syndrome.PMID:37431872 | DOI:10.5603/EP.a2023.0049 (Source: Endokrynologia Polska)
Source: Endokrynologia Polska - July 11, 2023 Category: Endocrinology Authors: Marta Opali ńska Aleksandra Gilis-Januszewska Karolina Morawiec-S ławek Anna Kurzy ńska Anna Sowa-Staszczak Anna Bogus ławska Ewelina Rzepka Alicja Hubalewska-Dydejczyk Source Type: research
Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas
CONCLUSIONS: Of all the features evaluated, only the multifocal nature of pancreatic neuroendocrine tumour (PanNET) lesions and a positive family history differentiated between patients with sporadic and MEN-1-related insulinomas. An age of insulinoma diagnosis of less than 30 years may be a strong indicator of an increased risk of MEN-1 syndrome.PMID:37431872 | DOI:10.5603/EP.a2023.0049 (Source: Endokrynologia Polska)
Source: Endokrynologia Polska - July 11, 2023 Category: Endocrinology Authors: Marta Opali ńska Aleksandra Gilis-Januszewska Karolina Morawiec-S ławek Anna Kurzy ńska Anna Sowa-Staszczak Anna Bogus ławska Ewelina Rzepka Alicja Hubalewska-Dydejczyk Source Type: research
Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas
CONCLUSIONS: Of all the features evaluated, only the multifocal nature of pancreatic neuroendocrine tumour (PanNET) lesions and a positive family history differentiated between patients with sporadic and MEN-1-related insulinomas. An age of insulinoma diagnosis of less than 30 years may be a strong indicator of an increased risk of MEN-1 syndrome.PMID:37431872 | DOI:10.5603/EP.a2023.0049 (Source: Endokrynologia Polska)
Source: Endokrynologia Polska - July 11, 2023 Category: Endocrinology Authors: Marta Opali ńska Aleksandra Gilis-Januszewska Karolina Morawiec-S ławek Anna Kurzy ńska Anna Sowa-Staszczak Anna Bogus ławska Ewelina Rzepka Alicja Hubalewska-Dydejczyk Source Type: research
Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas
CONCLUSIONS: Of all the features evaluated, only the multifocal nature of pancreatic neuroendocrine tumour (PanNET) lesions and a positive family history differentiated between patients with sporadic and MEN-1-related insulinomas. An age of insulinoma diagnosis of less than 30 years may be a strong indicator of an increased risk of MEN-1 syndrome.PMID:37431872 | DOI:10.5603/EP.a2023.0049 (Source: Endokrynologia Polska)
Source: Endokrynologia Polska - July 11, 2023 Category: Endocrinology Authors: Marta Opali ńska Aleksandra Gilis-Januszewska Karolina Morawiec-S ławek Anna Kurzy ńska Anna Sowa-Staszczak Anna Bogus ławska Ewelina Rzepka Alicja Hubalewska-Dydejczyk Source Type: research
Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas
CONCLUSIONS: Of all the features evaluated, only the multifocal nature of pancreatic neuroendocrine tumour (PanNET) lesions and a positive family history differentiated between patients with sporadic and MEN-1-related insulinomas. An age of insulinoma diagnosis of less than 30 years may be a strong indicator of an increased risk of MEN-1 syndrome.PMID:37431872 | DOI:10.5603/EP.a2023.0049 (Source: Endokrynologia Polska)
Source: Endokrynologia Polska - July 11, 2023 Category: Endocrinology Authors: Marta Opali ńska Aleksandra Gilis-Januszewska Karolina Morawiec-S ławek Anna Kurzy ńska Anna Sowa-Staszczak Anna Bogus ławska Ewelina Rzepka Alicja Hubalewska-Dydejczyk Source Type: research
Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas
CONCLUSIONS: Of all the features evaluated, only the multifocal nature of pancreatic neuroendocrine tumour (PanNET) lesions and a positive family history differentiated between patients with sporadic and MEN-1-related insulinomas. An age of insulinoma diagnosis of less than 30 years may be a strong indicator of an increased risk of MEN-1 syndrome.PMID:37431872 | DOI:10.5603/EP.a2023.0049 (Source: Endokrynologia Polska)
Source: Endokrynologia Polska - July 11, 2023 Category: Endocrinology Authors: Marta Opali ńska Aleksandra Gilis-Januszewska Karolina Morawiec-S ławek Anna Kurzy ńska Anna Sowa-Staszczak Anna Bogus ławska Ewelina Rzepka Alicja Hubalewska-Dydejczyk Source Type: research
Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas
CONCLUSIONS: Of all the features evaluated, only the multifocal nature of pancreatic neuroendocrine tumour (PanNET) lesions and a positive family history differentiated between patients with sporadic and MEN-1-related insulinomas. An age of insulinoma diagnosis of less than 30 years may be a strong indicator of an increased risk of MEN-1 syndrome.PMID:37431872 | DOI:10.5603/EP.a2023.0049 (Source: Endokrynologia Polska)
Source: Endokrynologia Polska - July 11, 2023 Category: Endocrinology Authors: Marta Opali ńska Aleksandra Gilis-Januszewska Karolina Morawiec-S ławek Anna Kurzy ńska Anna Sowa-Staszczak Anna Bogus ławska Ewelina Rzepka Alicja Hubalewska-Dydejczyk Source Type: research
Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas
CONCLUSIONS: Of all the features evaluated, only the multifocal nature of pancreatic neuroendocrine tumour (PanNET) lesions and a positive family history differentiated between patients with sporadic and MEN-1-related insulinomas. An age of insulinoma diagnosis of less than 30 years may be a strong indicator of an increased risk of MEN-1 syndrome.PMID:37431872 | DOI:10.5603/EP.a2023.0049 (Source: Endokrynologia Polska)
Source: Endokrynologia Polska - July 11, 2023 Category: Endocrinology Authors: Marta Opali ńska Aleksandra Gilis-Januszewska Karolina Morawiec-S ławek Anna Kurzy ńska Anna Sowa-Staszczak Anna Bogus ławska Ewelina Rzepka Alicja Hubalewska-Dydejczyk Source Type: research
Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas
CONCLUSIONS: Of all the features evaluated, only the multifocal nature of pancreatic neuroendocrine tumour (PanNET) lesions and a positive family history differentiated between patients with sporadic and MEN-1-related insulinomas. An age of insulinoma diagnosis of less than 30 years may be a strong indicator of an increased risk of MEN-1 syndrome.PMID:37431872 | DOI:10.5603/EP.a2023.0049 (Source: Endokrynologia Polska)
Source: Endokrynologia Polska - July 11, 2023 Category: Endocrinology Authors: Marta Opali ńska Aleksandra Gilis-Januszewska Karolina Morawiec-S ławek Anna Kurzy ńska Anna Sowa-Staszczak Anna Bogus ławska Ewelina Rzepka Alicja Hubalewska-Dydejczyk Source Type: research
Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas
CONCLUSIONS: Of all the features evaluated, only the multifocal nature of pancreatic neuroendocrine tumour (PanNET) lesions and a positive family history differentiated between patients with sporadic and MEN-1-related insulinomas. An age of insulinoma diagnosis of less than 30 years may be a strong indicator of an increased risk of MEN-1 syndrome.PMID:37431872 | DOI:10.5603/EP.a2023.0049 (Source: Endokrynologia Polska)
Source: Endokrynologia Polska - July 11, 2023 Category: Endocrinology Authors: Marta Opali ńska Aleksandra Gilis-Januszewska Karolina Morawiec-S ławek Anna Kurzy ńska Anna Sowa-Staszczak Anna Bogus ławska Ewelina Rzepka Alicja Hubalewska-Dydejczyk Source Type: research
Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas
CONCLUSIONS: Of all the features evaluated, only the multifocal nature of pancreatic neuroendocrine tumour (PanNET) lesions and a positive family history differentiated between patients with sporadic and MEN-1-related insulinomas. An age of insulinoma diagnosis of less than 30 years may be a strong indicator of an increased risk of MEN-1 syndrome.PMID:37431872 | DOI:10.5603/EP.a2023.0049 (Source: Endokrynologia Polska)
Source: Endokrynologia Polska - July 11, 2023 Category: Endocrinology Authors: Marta Opali ńska Aleksandra Gilis-Januszewska Karolina Morawiec-S ławek Anna Kurzy ńska Anna Sowa-Staszczak Anna Bogus ławska Ewelina Rzepka Alicja Hubalewska-Dydejczyk Source Type: research
